Correspondence 0001140361-25-008570 from Nanobiotix S.A. (NBTX)
Nanobiotix S.A.
Date: March 13, 2025 · CIK: 0001760854 · Accession: 0001140361-25-008570
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285604
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Alan Campbell Nanobiotix S.A. Registration Statement on Form F-3 (File No. 333-285604)
RE:
Dear Mr. Campbell:
In accordance with Rules 460 and 461 under the Securities Act of 1933, as amended, Nanobiotix S.A. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form F-3 to become effective on March 14, 2025 at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant also hereby requests that the Commission notify Peter Devlin of Jones Day at 212-326-3978 or pdevlin@jonesday.com to confirm that the Registration Statement has become effective.
Please contact Peter Devlin of Jones Day if you have any questions concerning the foregoing. Thank you for your attention to this matter.
Very truly yours,
NANOBIOTIX S.A.
Show Raw Text
CORRESP 1 filename1.htm Nanobiotix S.A. 60, rue de Wattignies 75012 Paris, France March 13, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Alan Campbell RE: Nanobiotix S.A. Registration Statement on Form F-3 (File No. 333-285604) Dear Mr. Campbell: In accordance with Rules 460 and 461 under the Securities Act of 1933, as amended, Nanobiotix S.A. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form F-3 to become effective on March 14, 2025 at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant also hereby requests that the Commission notify Peter Devlin of Jones Day at 212-326-3978 or pdevlin@jonesday.com to confirm that the Registration Statement has become effective. Please contact Peter Devlin of Jones Day if you have any questions concerning the foregoing. Thank you for your attention to this matter. Very truly yours, NANOBIOTIX S.A. By: /s/ François Chamoun Name: François Chamoun Title: VP General Counsel cc: Peter Devlin, Jones Day